We will compare the AMPD model to the traditional (Section II) PD model with regard to patients* and clinicians* experience of the clinical utility of both models. As the AMPD model was designed to improve clinical utility, we expect that both…
ID
Source
Brief title
Condition
- Personality disorders and disturbances in behaviour
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
The primary outcome is clinical utility as assessed by patients and clinicians
(clinical utility questionnaire - patient and clinician version).
Secondary outcome
Secondary outcomes are outcome expectancy (expectancy for future treatment
scale), satisfaction (Client satisfcation questionnaire), perceived benefits of
the assessment (assessment questionnaire), motivation for treatment (motivation
for treatment questionnaire) and an existing 6-item clinical utility scale for
clinicians.
Background summary
The traditional section II on Personality Disorder (PD) model has been
contested for its limited validity and lack of clinical utility. To counter
these shortcomings, DSM-5 has introduced in its section III an Alternative
Model for Personality Disorders (AMPD). Previous AMPD studies have focused on
separate criteria of the new model, e.g. by designing new instruments to assess
sections of the AMPD. No studies have investigated the full AMPD assessment
procedure and compared it to the existing, traditional DSM-5 PD assessment.
This project will compare both assessment procedures (traditional/categorical
(Section II) versus alternative/dimensional (Section III)) with regard to
different aspects of clinical utility, from both a patient and clinician
perspective.
Study objective
We will compare the AMPD model to the traditional (Section II) PD model with
regard to patients* and clinicians* experience of the clinical utility of both
models. As the AMPD model was designed to improve clinical utility, we expect
that both patients and clinicians will report stronger clinical utility for the
AMPD assessment procedure.
Study design
Randomized Controlled Trial. Patients referred to de Viersprong for assessment
and treatment will be randomly assigned to a traditional versus AMPD assessment
procedure. Both procedures are comparable in terms of their multi-method
approach and length of assessment and both have been manualized and approved by
international experts. After having finished the assessment procedure, patients
will complete a clinical utility questionnaire as well as questionnaires
concerning process variables like satisfaction, motivation, and treatment
readiness. Likewise, clinicians who will treat these patients, will assess the
assessment report for clinical utility regarding the treatment to come.
Intervention
In the traditional assessment procedure patients will have an intake consult
with a clinician and the SCID-5-P will be administered (i.e., assessment as
usual). In the AMPD admission procedure patients will be interviewed by a
clinician and the STiP 5.1 and SCID-AMPD-II will be administered.
Study burden and risks
Burden will be minimal. Number of sessions will be the same in both conditions
and also similar to the present standard assessment procedure (3 sessions).
Patients will be asked to complete questionnaires at the end of the assessment
procedure; an additional visit to the site is not necessary. Both groups will
receive DSM-5 diagnoses (when applicable), according to the respective model.
No impact is to be expected for treatment assignment.
De Beeklaan 2
Halsteren 4661EP
NL
De Beeklaan 2
Halsteren 4661EP
NL
Listed location countries
Age
Inclusion criteria
In order to be eligible to participate in this study, a subject must meet all
of the following criteria (inclusion criteria are similar to the general
criteria used in screening referrals at de Viersprong, all patients that are
screened and eligible for an admission procedure at de Viersprong will be
included):
(Presumed) personality disordered
Exclusion criteria
- IQ below 80
- Acute Psychotic disorder
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
In other registers
| Register | ID |
|---|---|
| CCMO | NL75676.018.20 |
| OMON | NL-OMON25774 |